Synergistic anti-tumor effects of the combination of a benzofuroxan derivate and sorafenib on NCI-H460 human large cell lung carcinoma cells (2014)
- Authors:
- USP affiliated authors: BYDLOWSKI, SERGIO PAULO - FM ; BARBUTO, JOSE ALEXANDRE MARZAGAO - ICB ; PIZZO, CELIA REGINA PINTO - ICB
- Unidades: FM; ICB
- DOI: 10.1016/j.biopha.2014.09.007
- Subjects: NEOPLASIAS PULMONARES (TERAPIA); APOPTOSE; FÁRMACOS (SISTEMA RESPIRATÓRIO); ANTINEOPLÁSICOS
- Language: Inglês
- Imprenta:
- Source:
- Título: Biomedicine & Pharmacotherapy
- ISSN: 0753-3322
- Volume/Número/Paginação/Ano: v. 68, n. 8, p. 1015-1022, 2014
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
TEIXEIRA, Sarah Fernandes et al. Synergistic anti-tumor effects of the combination of a benzofuroxan derivate and sorafenib on NCI-H460 human large cell lung carcinoma cells. Biomedicine & Pharmacotherapy, v. 68, n. 8, p. 1015-1022, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.biopha.2014.09.007. Acesso em: 14 fev. 2026. -
APA
Teixeira, S. F., Azevedo, R. A. de, Salomon, M. A. C., Jorge, S. D., Levy, D., Bydlowski, S. P., et al. (2014). Synergistic anti-tumor effects of the combination of a benzofuroxan derivate and sorafenib on NCI-H460 human large cell lung carcinoma cells. Biomedicine & Pharmacotherapy, 68( 8), 1015-1022. doi:10.1016/j.biopha.2014.09.007 -
NLM
Teixeira SF, Azevedo RA de, Salomon MAC, Jorge SD, Levy D, Bydlowski SP, Rodrigues CP, Pizzo CR, Barbuto JAM, Ferreira AK. Synergistic anti-tumor effects of the combination of a benzofuroxan derivate and sorafenib on NCI-H460 human large cell lung carcinoma cells [Internet]. Biomedicine & Pharmacotherapy. 2014 ; 68( 8): 1015-1022.[citado 2026 fev. 14 ] Available from: https://doi.org/10.1016/j.biopha.2014.09.007 -
Vancouver
Teixeira SF, Azevedo RA de, Salomon MAC, Jorge SD, Levy D, Bydlowski SP, Rodrigues CP, Pizzo CR, Barbuto JAM, Ferreira AK. Synergistic anti-tumor effects of the combination of a benzofuroxan derivate and sorafenib on NCI-H460 human large cell lung carcinoma cells [Internet]. Biomedicine & Pharmacotherapy. 2014 ; 68( 8): 1015-1022.[citado 2026 fev. 14 ] Available from: https://doi.org/10.1016/j.biopha.2014.09.007 - Monocyte-derived dendritic cells reflect the immune functional status of a chromophobe renal cell carcinoma patient: could it be a general phenomenon?
- Mastoparan induces apoptosis in B16F10-Nex2 melanoma cells via the intrinsic mitochondrial pathway and displays antitumor activity in vivo
- Tumour cells incorporate exosomes derived from dendritic cells through a mechanism involving the Tetraspanin CD9
- Are dysfunctional monocyte-derived dendritic cells in cancer an explanation for cancer vaccine failures?
- Dendritic cell membrane CD83 enhances immune responses by boosting intracellular calcium release in T lymphocytes
- Hemophagocytic lymphohistiocytosis: a rare diagnosis, an even rarer opportunity to appraise our understanding of the immune system
- Tolerância imunológica
- Imunidade celular
- Dendritic cell-based cancer vaccine with plasmid expressing thymidine kinase suicide gene and immunomodulatory evolved interleukin-12 gene for medullary thyroid carcinoma
- Anti-proliferative effects of guarana (Paulinia cupana Mart var. Sorbilis) in pulmonary melanoma colonies
Informações sobre o DOI: 10.1016/j.biopha.2014.09.007 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
